Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients

2014 Surveillance, Epidemiology, and End Results (SEER) Program. Research data, 1975-2007. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Available at: http://www.seer.cancer.gov. Accessed March 1, 2015. Howington, 2013, Treatment of stage I and II non–small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 143, e278S, 10.1378/chest.12-2359 Little, 2007, National survey of non–small cell lung cancer in the United States: epidemiology, pathology and patterns of care, Lung Cancer, 57, 253, 10.1016/j.lungcan.2007.03.012 Ginsberg, 1995, Randomized trial of lobectomy versus limited resection for T1 N0 non–small cell lung cancer. Lung Cancer Study Group, Ann Thorac Surg, 60, 615, 10.1016/0003-4975(95)00537-U Landreneau, 1997, Wedge resection versus lobectomy for stage I (T1 N0 M0) non–small-cell lung cancer, J Thorac Cardiovasc Surg, 113, 691, 10.1016/S0022-5223(97)70226-5 Martini, 1995, Incidence of local recurrence and second primary tumors in resected stage I lung cancer, J Thorac Cardiovasc Surg, 109, 120, 10.1016/S0022-5223(95)70427-2 Jeremic, 2002, Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non–small-cell lung cancer, Int J Radiat Oncol Biol Phys, 54, 119, 10.1016/S0360-3016(02)02917-6 Ginsberg, 1988 Datta, 2003, Preoperative evaluation of patients undergoing lung resection surgery, Chest, 123, 2096, 10.1378/chest.123.6.2096 Alberts, 2007, Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd edition), Chest, 132, 1S, 10.1378/chest.07-1860 Leonard, 2000, Primary non–small-cell lung cancer: determining the suitability of the patient and tumor for resection, Curr Opin Pulm Med, 6, 391, 10.1097/00063198-200007000-00023 El-Sherif, 2005, New therapeutic approaches for early stage non–small cell lung cancer, Surg Oncol, 14, 27, 10.1016/j.suronc.2004.11.002 Bach, 1999, Racial differences in the treatment of early-stage lung cancer, N Engl J Med, 341, 1198, 10.1056/NEJM199910143411606 Miller, 1987, Limited resection of bronchogenic carcinoma in the patient with marked impairment of pulmonary function, Ann Thorac Surg, 44, 340, 10.1016/S0003-4975(10)63785-X Errett, 1985, Wedge resection as an alternative procedure for peripheral bronchogenic–carcinoma in poor-risk patients, J Thorac Cardiov Surg, 90, 656, 10.1016/S0022-5223(19)38531-9 Warren, 1994, Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence, J Thorac Cardiovasc Surg, 107, 1087, 10.1016/S0022-5223(12)70385-9 Shennib, 1999, Sublobar resection for lung cancer, Eur J Cardiothorac Surg, 16, S61, 10.1016/S1010-7940(99)00189-X Ginsberg, 1994, The comparison of limited resection to lobectomy for T1N0 non–small cell lung cancer. LCSG 821, Chest, 106, 318S Wisnivesky, 2010, Limited resection for the treatment of patients with stage IA lung cancer, Ann Surg, 251, 550, 10.1097/SLA.0b013e3181c0e5f3 Okada, 2001, Is segmentectomy with lymph node assessment an alternative to lobectomy for non–small cell lung cancer of 2 cm or smaller?, Ann Thorac Surg, 71, 956, 10.1016/S0003-4975(00)02223-2 Koike, 2003, Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer, J Thorac Cardiovasc Surg, 125, 924, 10.1067/mtc.2003.156 Kodama, 1997, Intentional limited resection for selected patients with T1 N0 M0 non–small-cell lung cancer: a single-institution study, J Thorac Cardiovasc Surg, 114, 347, 10.1016/S0022-5223(97)70179-X Kates, 2011, Survival following lobectomy and limited resection for the treatment of stage I non–small cell lung cancer <= 1 cm in size: a review of SEER data, Chest, 139, 491, 10.1378/chest.09-2547 Little, 2005, Patterns of surgical care of lung cancer patients, Ann Thorac Surg, 80, 2051, 10.1016/j.athoracsur.2005.06.071 Mery, 2005, Similar long-term survival of elderly patients with non–small cell lung cancer treated with lobectomy or wedge resection within the Surveillance, Epidemiology, and End Results database, Chest, 128, 237, 10.1378/chest.128.1.237 Keenan, 2004, Segmental resection spares pulmonary function in patients with stage I lung cancer, Ann Thorac Surg, 78, 228, 10.1016/j.athoracsur.2004.01.024 Okada, 2006, Radical sublobar resection for small-sized non–small cell lung cancer: a multicenter study, J Thorac Cardiovasc Surg, 132, 769, 10.1016/j.jtcvs.2006.02.063 El-Sherif, 2006, Outcomes of sublobar resection versus lobectomy for stage I non–small cell lung cancer: a 13-year analysis, Ann Thorac Surg, 82, 408, 10.1016/j.athoracsur.2006.02.029 Sienel, 2007, Frequency of local recurrence following segmentectomy of stage IA non–small cell lung cancer is influenced by segment localisation and width of resection margins—implications for patient selection for segmentectomy, Eur J Cardiothorac Surg, 31, 522, 10.1016/j.ejcts.2006.12.018 Kraev, 2007, Wedge resection vs lobectomy: 10-year survival in stage I primary lung cancer, Chest, 131, 136, 10.1378/chest.06-0840 Pastorino, 1991, Limited resection for stage I lung cancer, Eur J Surg Oncol, 17, 42 Read, 1990, Survival after conservative resection for T1 N0 M0 non–small cell lung cancer, Ann Thorac Surg, 49, 391, 10.1016/0003-4975(90)90242-X Martin-Ucar, 2005, A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients, Eur J Cardiothorac Surg, 27, 675, 10.1016/j.ejcts.2005.01.006 De Giacomo, 2009, Sub-lobar lung resection of peripheral T1N0M0 NSCLC does not affect local recurrence rate, Scand J Surg, 98, 225, 10.1177/145749690909800406 Howington, 2012, In-hospital clinical and economic consequences of pulmonary wedge resections for cancer using video-assisted thoracoscopic techniques vs. traditional open resections: a retrospective database analysis, Chest, 141, 429, 10.1378/chest.10-3013 Schuchert, 2007, Anatomic segmentectomy in the treatment of stage I non–small cell lung cancer, Ann Thorac Surg, 84, 926, 10.1016/j.athoracsur.2007.05.007 Parashar, 2010, Limited resection followed by intraoperative seed implantation is comparable to stereotactic body radiotherapy for solitary lung cancer, Cancer, 116, 5047, 10.1002/cncr.25441 Bishawi, 2012, Pulmonary function testing after stereotactic body radiotherapy to the lung, Int J Radiat Oncol Biol Phys, 82, e107, 10.1016/j.ijrobp.2011.01.037 Sher, 2011, Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non–small cell lung cancer, Int J Radiat Oncol Biol Phys, 81, e767, 10.1016/j.ijrobp.2010.10.074 Manning, 2001, Biologic treatment planning for high-dose-rate brachytherapy, Int J Radiat Oncol Biol Phys, 49, 839, 10.1016/S0360-3016(00)01453-X d'Amato, 1998, Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer, Chest, 114, 1112, 10.1378/chest.114.4.1112 Chen, 1999, Intraoperative 125I brachytherapy for high-risk stage I non–small cell lung carcinoma, Int J Radiat Oncol Biol Phys, 44, 1057, 10.1016/S0360-3016(99)00133-9 Voynov, 2005, Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non–small cell lung cancer, Brachytherapy, 4, 278, 10.1016/j.brachy.2005.03.007 Lee, 2003, Limited resection for non–small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds, Ann Thorac Surg, 75, 237, 10.1016/S0003-4975(02)04098-5 Santos, 2003, Comparison between sublobar resection and 125iodine brachytherapy after sublobar resection in high-risk patients with stage I non–small-cell lung cancer, Surgery, 134, 691, 10.1016/S0039-6060(03)00327-1 Fernando, 2005, Lobar and sublobar resection with and without brachytherapy for small stage IA non–small cell lung cancer, J Thorac Cardiovasc Surg, 129, 261, 10.1016/j.jtcvs.2004.09.025 Birdas, 2006, Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer, Ann Thorac Surg, 81, 434, 10.1016/j.athoracsur.2005.08.052 Martinez-Monge, 2008, CT-guided permanent brachytherapy for patients with medically inoperable early-stage non–small cell lung cancer (NSCLC), Lung Cancer, 61, 209, 10.1016/j.lungcan.2007.12.016 Fernando, 2014, Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non–small-cell lung cancer, J Clin Oncol, 32, 2456, 10.1200/JCO.2013.53.4115 Fernando, 2011, The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial, J Thorac Cardiovasc Surg, 142, 554, 10.1016/j.jtcvs.2010.10.061 McGahan, 1990, Hepatic ablation using radiofrequency electrocautery, Invest Radiol, 25, 267, 10.1097/00004424-199003000-00011 Abbas, 2009, Radiofrequency and microwave ablation of lung tumors, J Surg Oncol, 100, 645, 10.1002/jso.21334 White, 2008, Radiofrequency ablation for primary lung cancer and pulmonary metastases, Clin Lung cancer, 9, 16, 10.3816/CLC.2008.n.003 Lencioni, 2004, Radiofrequency ablation of lung malignancies: where do we stand?, Cardiovasc Intervent Radiol, 27, 581, 10.1007/s00270-004-0008-6 Sharma, 2012, Image-guided ablative therapies for lung cancer, Radiol Clin North Am, 50, 975, 10.1016/j.rcl.2012.06.004 Lee, 2004, Percutaneous radiofrequency ablation for inoperable non–small cell lung cancer and metastases: preliminary report, Radiology, 230, 125, 10.1148/radiol.2301020934 Huang, 2011, Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies?, Eur J Cardiothorac Surg, 39, 348, 10.1016/j.ejcts.2010.06.004 Beland, 2010, Primary non–small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation, Radiology, 254, 301, 10.1148/radiol.00000090174 Fernando, 2005, Radiofrequency ablation for the treatment of non–small cell lung cancer in marginal surgical candidates, J Thorac Cardiovasc Surg, 129, 639, 10.1016/j.jtcvs.2004.10.019 Hiraki, 2006, Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors, Cancer, 107, 2873, 10.1002/cncr.22333 Yan, 2006, Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival, Ann Surg Oncol, 13, 1529, 10.1245/s10434-006-9101-1 Ambrogi, 2007, Radiofrequency ablation of inoperable non–small cell lung cancer, J Thorac Oncol, 2, 2, 10.1097/01.JTO.0000268631.79906.18 Pennathur, 2007, Radiofrequency ablation for the treatment of stage I non–small cell lung cancer in high-risk patients, J Thorac Cardiovasc Surg, 134, 857, 10.1016/j.jtcvs.2007.04.060 Simon, 2007, Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients, Radiology, 243, 268, 10.1148/radiol.2431060088 Lencioni, 2008, Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study), Lancet Oncol, 9, 621, 10.1016/S1470-2045(08)70155-4 Lanuti, 2009, Radiofrequency ablation for treatment of medically inoperable stage I non–small cell lung cancer, J Thorac Cardiovasc Surg, 137, 160, 10.1016/j.jtcvs.2008.08.034 Casal, 2010, Radiofrequency ablation of lung tumors, Clin Chest Med, 31, 151, 10.1016/j.ccm.2009.08.021 Bilal, 2012, Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non–small cell lung cancer?, Interact Cardiovasc Thorac Surg, 15, 258, 10.1093/icvts/ivs179 Simon, 2005, Current role of image-guided ablative therapies in lung cancer, Expert Rev Anticancer Ther, 5, 657, 10.1586/14737140.5.4.657 Simon, 2005, Microwave ablation: principles and applications, Radiographics, 25, S69, 10.1148/rg.25si055501 Organ, 1976, Electrophysiologic principles of radiofrequency lesion making, Appl Neurophysiol, 39, 69 Skinner, 1998, A theoretical comparison of energy sources—microwave, ultrasound and laser—for interstitial thermal therapy, Phys Med Biol, 43, 3535, 10.1088/0031-9155/43/12/011 Goldberg, 1996, Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode, Acad Radiol, 3, 636, 10.1016/S1076-6332(96)80188-7 Lu, 2001, Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy, Radiology, 221, 167, 10.1148/radiol.2211001783 Feng, 2002, Percutaneous microwave coagulation therapy for lung cancer, Zhonghua Zhong Liu Za Zhi, 24, 388 Wolf, 2008, Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients, Radiology, 247, 871, 10.1148/radiol.2473070996 Wang, 2005, Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures, Radiology, 235, 289, 10.1148/radiol.2351030747 Hoffmann, 2002, The cryobiology of cryosurgical injury, Urology, 60, 40, 10.1016/S0090-4295(02)01683-7 Gage, 1998, Mechanisms of tissue injury in cryosurgery, Cryobiology, 37, 171, 10.1006/cryo.1998.2115 Niu, 2012, Cryosurgery for lung cancer, J Thorac Dis, 4, 408 Sabel, 2005, Immunologic response to cryoablation of breast cancer, Breast Cancer Res Treat, 90, 97, 10.1007/s10549-004-3289-1 Littrup, 1994, Prostatic cryotherapy: ultrasonographic and pathologic correlation in the canine model, Urology, 44, 175, 10.1016/S0090-4295(94)80123-1 Vergnon, 2006, Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers, Eur Respir J, 28, 200, 10.1183/09031936.06.00014006 Kawamura, 2006, Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates, J Thorac Cardiovasc Surg, 131, 1007, 10.1016/j.jtcvs.2005.12.051 Maiwand, 2004, Cryosurgery for lung cancer: clinical results and technical aspects, Technol Cancer Res Treat, 3, 143, 10.1177/153303460400300207 Choe, 2009, The use of PTC and RFA as treatment alternatives with low procedural morbidity in non–small cell lung cancer, Eur J Cancer, 45, 1773, 10.1016/j.ejca.2009.02.016 Zemlyak, 2010, Comparison of survival after sublobar resections and ablative therapies for stage I non–small cell lung cancer, J Am Coll Surg, 211, 68, 10.1016/j.jamcollsurg.2010.03.020 Yamauchi, 2012, Percutaneous cryoablation for the treatment of medically inoperable stage I non–small cell lung cancer, PLoS One, 7, e33223, 10.1371/journal.pone.0033223 Simone, 2012, Photodynamic therapy for the treatment of non–small cell lung cancer, J Thorac Dis, 4, 63 Agostinis, 2011, Photodynamic therapy of cancer: an update, CA Cancer J Clin, 61, 250, 10.3322/caac.20114 Dougherty, 1998, Photodynamic therapy, J Natl Cancer Inst, 90, 889, 10.1093/jnci/90.12.889 Vrouenraets, 2003, Basic principles, applications in oncology and improved selectivity of photodynamic therapy, Anticancer Res, 23, 505 Wisnivesky, 2013, Diagnosis and treatment of bronchial intraepithelial neoplasia and early lung cancer of the central airways: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 143, e263S, 10.1378/chest.12-2358 Sheski, 2000, Endoscopic treatment of early-stage lung cancer, Cancer Control, 7, 35, 10.1177/107327480000700103 Furuse, 1993, A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group, J Clin Oncol, 11, 1852, 10.1200/JCO.1993.11.10.1852 Kato, 2006, Basic and clinical research on photodynamic therapy at Tokyo Medical University Hospital, Lasers Surg Med, 38, 371, 10.1002/lsm.20346 Okunaka, 2004, Photodynamic therapy for peripheral lung cancer, Lung Cancer, 43, 77, 10.1016/j.lungcan.2003.08.016 Sibley, 1998, Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma: smaller volumes and higher doses—a review, Cancer, 82, 433, 10.1002/(SICI)1097-0142(19980201)82:3<433::AID-CNCR2>3.0.CO;2-Q Qiao, 2003, The role of radiotherapy in treatment of stage I non–small cell lung cancer, Lung Cancer, 41, 1, 10.1016/S0169-5002(03)00152-1 Mehta, 2001, A new approach to dose escalation in non–small-cell lung cancer, Int J Radiat Oncol Biol Phys, 49, 23, 10.1016/S0360-3016(00)01374-2 Fowler, 2000, Non–small cell lung tumors repopulate rapidly during radiation therapy, Int J Radiat Oncol Biol Phys, 46, 516, 10.1016/S0360-3016(99)00364-8 Martel, 1999, Estimation of tumor control probability model parameters from 3-D dose distributions of non–small cell lung cancer patients, Lung Cancer, 24, 31, 10.1016/S0169-5002(99)00019-7 Leksell, 1951, The stereotaxic method and radiosurgery of the brain, Acta Chir Scand, 102, 316 Lax, 1994, Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects, Acta Oncol, 33, 677, 10.3109/02841869409121782 Blomgren, 1995, Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients, Acta Oncol, 34, 861, 10.3109/02841869509127197 Kavanagh, 2006, Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases, Semin Radiat Oncol, 16, 77, 10.1016/j.semradonc.2005.12.003 Chi, 2010, Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non–small-cell lung cancer: clinical implications, Radiother Oncol, 94, 1, 10.1016/j.radonc.2009.12.008 Hof, 2007, Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC), Cancer, 110, 148, 10.1002/cncr.22763 Douglas, 1976, The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation, Radiat Res, 66, 401, 10.2307/3574407 Fowler, 2004, A challenge to traditional radiation oncology, Int J Radiat Oncol Biol Phys, 60, 1241, 10.1016/j.ijrobp.2004.07.691 Timmerman, 2003, Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non–small cell lung cancer, Chest, 124, 1946, 10.1378/chest.124.5.1946 McGarry, 2005, Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: phase I study, Int J Radiat Oncol Biol Phys, 63, 1010, 10.1016/j.ijrobp.2005.03.073 Timmerman, 2006, Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer, J Clin Oncol, 24, 4833, 10.1200/JCO.2006.07.5937 Bradley, 2010, Stereotactic body radiation therapy for early-stage non–small-cell lung cancer: the pattern of failure is distant, Int J Radiat Oncol Biol Phys, 77, 1146, 10.1016/j.ijrobp.2009.06.017 Timmerman, 2010, Stereotactic body radiation therapy for inoperable early stage lung cancer, JAMA, 303, 1070, 10.1001/jama.2010.261 Timmerman, 2014, Long-term results of RTOG 0236: a phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I non–small cell lung cancer, Int J Radiat Oncol Biol Phys, 90, S30, 10.1016/j.ijrobp.2014.05.135 Le, 2006, Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors, J Thorac Oncol, 1, 802, 10.1016/S1556-0864(15)30409-3 Koto, 2007, A phase II study on stereotactic body radiotherapy for stage I non–small cell lung cancer, Radiother Oncol, 85, 429, 10.1016/j.radonc.2007.10.017 Onishi, 2007, Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non–small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study, J Thorac Oncol, 2, S94, 10.1097/JTO.0b013e318074de34 Lagerwaard, 2008, Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non–small-cell lung cancer, Int J Radiat Oncol Biol Phys, 70, 685, 10.1016/j.ijrobp.2007.10.053 Baumann, 2009, Outcome in a prospective phase II trial of medically inoperable stage I non–small-cell lung cancer patients treated with stereotactic body radiotherapy, J Clin Oncol, 27, 3290, 10.1200/JCO.2008.21.5681 Inoue, 2009, Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination, Int J Radiat Oncol Biol Phys, 75, 683, 10.1016/j.ijrobp.2008.11.026 Guckenberger, 2009, Dose–response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation, Int J Radiat Oncol Biol Phys, 74, 47, 10.1016/j.ijrobp.2008.06.1939 Fakiris, 2009, Stereotactic body radiation therapy for early-stage non–small-cell lung carcinoma: four-year results of a prospective phase II study, Int J Radiat Oncol Biol Phys, 75, 677, 10.1016/j.ijrobp.2008.11.042 Stephans, 2009, A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non–small cell lung cancer: the Cleveland Clinic experience, J Thorac Oncol, 4, 976, 10.1097/JTO.0b013e3181adf509 Haasbeek, 2010, Stage I nonsmall cell lung cancer in patients aged > or = 75 years: outcomes after stereotactic radiotherapy, Cancer, 116, 406, 10.1002/cncr.24759 Louie, 2014, When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer? A decision analysis, Chest, 146, 1021, 10.1378/chest.13-2924